You are here

Disease Prevention

Mounting Data Indicates That the J.&J. Vaccine Holds Its Own

Roughly 17 million Americans received the Johnson & Johnson Covid vaccine, only to be told later that it was the least protective of the options available in the United States. But new data suggest that the vaccine is now preventing infections, hospitalizations and deaths at least as well as the Pfizer-BioNTech and Moderna vaccines.

The reasons aren’t clear, and not all experts are convinced that the vaccine has vindicated itself. But the accumulating data nonetheless offer considerable reassurance to recipients of the vaccine and, if confirmed, have broad implications for its deployment in parts of the world.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Long Covid patients, in search of relief, turn to private company. Critics say there's no science to back it up.

Long Covid patients, in search of relief, turn to private company

NBC News

A full two years into the coronavirus pandemic, long-haul Covid patients remain sick and in desperate search of answers. They've lost jobs. They've lost their sense of self. Many say they have lost faith in the medical community.

Despite multiple studies, the launch of dozens of specialized long Covid clinics and $1.15 billion in federal funding for the National Institutes of Health to study the condition, there remains a dearth of proven treatments for people who are suffering from lingering illness after their infection. 

"There is no one right answer for many of our patients," said Dr. Ben Abramoff, director of the Post-COVID Assessment and Recovery Clinic at Penn Medicine, which has seen more than 1,100 long Covid patients.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Disease Prevention
howdy folks
Page loaded in 0.789 seconds.